---
title: "Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes Dividend"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280379131.md"
description: "Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes Dividend"
datetime: "2026-03-24T22:43:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280379131.md)
  - [en](https://longbridge.com/en/news/280379131.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280379131.md)
generator: "portal-rs"
---

# Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes Dividend

Tianjin Development’s Pharma Unit Lisheng Posts Profit Surge and Proposes Dividend

### Related Stocks

- [002393.CN](https://longbridge.com/en/quote/002393.CN.md)
- [00882.HK](https://longbridge.com/en/quote/00882.HK.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)

## Related News & Research

- [Tianjin Development Flags Sharp Profit Drop at Lisheng Pharmaceutical for H1 2026](https://longbridge.com/en/news/292682022.md)
- [Tianjin Development Holdings files board, committee and management disclosure roster](https://longbridge.com/en/news/294491882.md)
- [Tianjin Lisheng Pharma, Tianjin Development Holdings subsidiary, posts H1 net profit RMB 80.08 million](https://longbridge.com/en/news/296541476.md)
- [China's 1H25 Innovative Drug Out-Licensing Deal Value Exceeds USD100 Billion, Hitting New High](https://longbridge.com/en/news/293168428.md)
- [Tianjin Development Secures HK$100 Million Revolving Loan Tied to State Majority Control](https://longbridge.com/en/news/284576057.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**